Purity: ≥99.4%
Weight Management / Metabolic Peptides
Retatrutide Pen (Alluvi Healthcare)
Retatrutide is a novel, triple agonist peptide that targets the GLP-1, GIP, and glucagon receptors—designed to support metabolic balance and weight management.
$50.00
Dosage20mg
StockIn Stock (1000)
Purity≥99.4%
CAS2381089-83-2
Select Dosage
Quantity
1
Dosage Summary: 1 x $50.00
For laboratory research use only. Not intended for human consumption.
Molecular Formula
C221H342N46O68
Purity
≥99.4%
Storage
-20°C
Half Life
6 days
Product Overview
About Retatrutide Pen (Alluvi Healthcare)
Retatrutide is a novel, triple agonist peptide that targets the GLP-1, GIP, and glucagon receptors—designed to support metabolic balance, weight management, and overall well-being through a multi-pathway therapeutic approach.
Product Details:
- CAS: 2381089-83-2
- FORMULA: C221H342N46O68
- MW: 4010.3 g/mol
- SEQUENCE: Y-Aib-EGTFTSDYSileLDKIAQ-DFVQWLIAGGPSSGAPPPS-NH₂
Store in a refrigerator (2°C to 8°C). For subcutaneous injection only. Read package leaflet before use.
Verified Testing
Certificate Of
Analysis
Every batch undergoes rigorous third-party analytical testing to confirm purity, identity, and consistency standards.
View COA